Top

Hepatology International

Published in:

01-06-2009 | Original Article

Liver cirrhosis and hepatocellular carcinoma in hepatic vena cava disease, a liver disease caused by obstruction of inferior vena cava

Author: Santosh Man Shrestha

Published in: Hepatology International | Issue 2/2009

Abstract

Purpose

Hepatic vena cava disease (HVD), a form of Budd-Chiari syndrome, is caused by the obstruction of hepatic portion of the inferior vena cava. It is a chronic disease characterized by the development of liver cirrhosis (LC) and hepatocellular carcinoma (HCC). As HVD occurred in areas with high incidence of hepatitis B virus (HBV) infection and some patients tested HBsAg positive, it was thought to be the cause of LC and HCC. To assess the pathogenesis of LC or HCC in HVD, a long-term follow-up study was done.

Method

Fifty-six patients with HVD diagnosed by ultrasound (US) and confirmed by cavography in 31 and liver biopsy in 34 were followed up for an average of 14.8 ± 9 years. The occurrence of LC was diagnosed by US and/or liver biopsy and that of HCC by US, elevated level of α-fetoprotein, and liver biopsy or fine-needle aspiration cytology, or computed tomographic scan. Other risk factors for LC/HCC such as alcohol use and HBV and hepatitis C virus (HCV) infections were assayed.

Results

Forty-four (78.5%) and 6 (10.7%) patients developed cirrhosis and HCC, respectively. LC/HCC occurred more frequently among those who had severe or frequent acute exacerbations (P = 0.017), but it was not related to alcohol use or HBV and HCV infections.

Conclusion

HVD is independent risk factors for LC and HCC. Severe and/or recurrent loss of hepatocytes caused by hepatic venous outflow obstruction and/or thrombotic obstruction of small radicals of hepatic and portal veins that occurred during acute exacerbations was considered important in the pathogenesis of LC and HCC in HVD.

Yamamoto S, Yokoyama Y, Takeshige K, Iwatsuki S. Budd-Chiari syndrome with obstruction of the inferior vena cava. Gastroenterology 1968;54:1070–1084PubMed

Nakamura T, Nakamura S, Aikawa T, Suzuki O, Onodera A, Karoji N. Obstruction of the inferior vena cava in the hepatic portion and the hepatic veins: report of eight cases and review of the Japanese literature. Angiology 1968;19:479–498. doi:10.1177/000331976801900805 PubMedCrossRef

Takeuchi J, Takada A, Hasumura Y, Matsuda Y, Ikegami F. Budd-Chiari syndrome associated with obstruction of the inferior vena cava. Am J Med 1971;51:11–20. doi:10.1016/0002-9343(71)90319-6 PubMedCrossRef

Kimura C, Matsuda S, Koie H, Hirooka M. Membranous obstruction of the hepatic portion of the inferior vena cava: clinical study of nine cases. Surgery 1972;72:551–559PubMed

Nakamura S, Takezawa Y. Follow-up study of 13 cases of IVCO from 1958–1974. Tohoku J Exp Med 1982;138:119–120. doi:10.1620/tjem.138.119 PubMedCrossRef

Datta DV, Samanta SS, Singh A, Gupta BB, Aikat BK, Chhuttani PN. Clinical spectrum of Budd-Chiari syndrome in Chandigrah with particular reference to obstruction of intrahepatic portion of inferior vena cava. Indian J Med Res 1972;60:385–402PubMed

Dilawari JB, Bambery P, Chawla Y, Kaur U, Bhusnurmath SR, Malhotra HS, et al. Hepatic outflow obstruction (Budd-Chiari syndrome) experience with 177 patients and a review of literature. Medicine 1994;73:21–36. doi:10.1097/00005792-199401000-00003 PubMedCrossRef

Wang ZG. Management of Budd-Chiari syndrome: experience from 430 cases. Asian J Surg 1996;19:23–30

Shrestha SM, Okuda K, Uchida T, Maharjan KG, Shrestha S, Joshi BL, et al. Endemicity and clinical picture of liver disease due to obstruction of the hepatic portion of the inferior vena cava in Nepal. J Gastroenterol Hepatol 1996;11:170–179. doi:10.1111/j.1440-1746.1996.tb00056.x PubMedCrossRef

10.

Bronte-Stewart B, Goetz RH. Budd-Chiari’s syndrome: high inferior vena caval obstruction demonstrated by venography. Angiology 1952;3:167–178. doi:10.1177/000331975200300203 CrossRef

11.

Simson IW. Membranous obstruction of the inferior vena cava and hepatocellular carcinoma in South Africa. Gastroenterology 1982;82:171–178PubMed

12.

Kew MC, McKnight A, Hodkinson J, Bukofzer S, Esser JD. The role of membranous obstruction in the inferior vena cava in the etiology of hepatocellular carcinoma in Southern African blacks. Hepatology 1989;9:121–125. doi:10.1002/hep.1840090121 PubMedCrossRef

13.

Schaffner F, Gadboys HL, Safran AP, Baron MG, Aufses AH. Budd Chiari syndrome caused by a web in the inferior vena cava. Am J Med 1967;42:838–843. doi:10.1016/0002-9343(67)90100-3 PubMedCrossRef

14.

Rector WG Jr, Xu YH, Goldstein L, Peters RL, Reynolds TB. Membranous obstruction of the inferior vena cava in the United States. Medicine 1985;64:134–143. doi:10.1097/00005792-198503000-00005 PubMedCrossRef

15.

Shrestha SM, Shrestha S. Hepatic vena cava disease: etiologic relation to bacterial infection. Hepatol Res 2007;37:196–204. doi:10.1111/j.1872-034X.2007.00012.x PubMedCrossRef

16.

Okuda K, Kage M, Shrestha SM. Proposal of new nomenclature for Budd-Chiari syndrome: hepatic vein thrombosis versus thrombosis of the inferior vena cava at its hepatic portion. Hepatology 1998;28:1191–1198. doi:10.1002/hep.510280505 PubMedCrossRef

17.

Okuda K. Inferior vena cava thrombosis at its hepatic portion (obliterative hepatocavopathy). Semin Liver Dis 2002;22:15–26. doi:10.1055/s-2002-23203 PubMedCrossRef

18.

Okuda H, Yamagata H, Obata H, Iwata H, Sasaki R, Imai F, et al. Epidemiological and clinical features of Budd-Chiari syndrome in Japan. J Hepatol 1995;22:1–9. doi:10.1016/0168-8278(95)80252-5 PubMedCrossRef

19.

Okuda K. Membranous obstruction of the inferior vena cava: etiology and relation to hepatocellular carcinoma. Hepatology 1982;82:376–379

20.

Shrestha SM, Shrestha S, Shrestha A, Tsuda F, Endo K, Takahashi M, et al. High prevalence of hepatitis B virus infection and inferior vena cava obstruction among patients with liver cirrhosis or hepatocellular carcinoma in Nepal. J Gastroenterol Hepatol 2007;22:1921–1928. doi:10.1111/j.1440-1746.2006.04611.x PubMedCrossRef

21.

Takayasu K, Muramatsu Y, Moriyama N, Wakao F, Makuuchi M, Takayama T, et al. Radiological study of idiopathic Budd-Chiari syndrome complicated by hepatocellular carcinoma. A report of four cases. Am J Gastroenterol 1994;89:249–253PubMed

22.

Shrestha SM. Seroepidemiology of hepatitis B in Nepal. J Commun Dis 1990;22(1):27–32PubMed

23.

Arora A, Sharma MP, Acharya SK, Panda SK, Berry M. Diagnostic utility of ultrasonography in hepatic venous outflow tract obstruction in a tropical country. J Gastroenterol Hepatol 1991;6:368–373. doi:10.1111/j.1440-1746.1991.tb00873.x PubMedCrossRef

24.

Makuchi M, Hasegawa H, Yamazaki S, Moriyama N, Takayasu K, Okazaki M. Primary Budd-Chiari syndrome: ultrasonic demonstration. Radiology 1984;152:775–779

25.

Datta DV, Vashishta S, Samanta AK, Chttani PN. Diagnostic value of combined transhepatic venography and inferior vena cavography in chronic Budd-Chiari syndrome. Dig Dis 1978;23:1031–1041. doi:10.1007/BF01263104 CrossRef

26.

Shrestha SM, Joshi BL, Shrestha S, Maharjan KG. Cavographic study of an early stage of obstruction of the hepatic portion of inferior vena cava. J Gastroenterol Hepatol 2000;15:202–210. doi:10.1046/j.1440-1746.2000.02043.x PubMedCrossRef

27.

Okumura H, Kawamura O, Kishimoto S, Hasegawa A, Shrestha SM, Okuda K, et al. Aflatoxin M1 in Nepalese sera, quantified by combination of monoclonoal antibody immunoaffinity chromatography and enzyme-linked immunosorbent assay. Carcinogenesis 1993;14:1233–1235. doi:10.1093/carcin/14.6.1233 PubMedCrossRef

28.

Kiyosawa K, Sodeyama T, Tanaka E, Gibo Y, Yoshizawa K, Nakano Y, et al. Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: analysis by detection of antibody to hepatitis C virus. Hepatology 1990;12:671–675. doi:10.1002/hep.1840120409 PubMedCrossRef

29.

Salaspuro MP, Lieber CS. Alcoholic Liver Disease. In Wright R, Alberti KGMM, Karran A, Millward-Sadler GHM, editors. Liver and Biliary Disease. London: W.B. Saunders; 1979

30.

Tanaka M, Wanless IR. Pathology of the liver in Budd-Chiari syndrome: portal vein thrombosis and histogenesis of veno-centric cirrhosis, veno-portal cirrhosis, and large regenerative nodules. Hepatology 1998;27:488–496. doi:10.1002/hep.510270224 PubMedCrossRef

31.

Akiyoshi H, Terada T. Centrilobular and perisinusoidal fibrosis in congestive liver in rat. J Hepatol 1999;30:433–439. doi:10.1016/S0168-8278(99)80102-0 PubMedCrossRef

32.

Parkar RGF. Occlusion of hepatic veins in man. Medicine 1959;38:369–402

33.

Shrestha SM, Shrestha S. Bacterial peritonitis in inferior hepatic vena cava disease: a hypothesis to explain the cause of infection in high protein ascites. Hepatol Res 2002;24:42–49. doi:10.1016/S1386-6346(02)00018-9 PubMedCrossRef

34.

Mann JD, Hall IW. Obstruction of the inferior vena cava. Edinburgh Med J 1904;16:56–62

35.

Rigdon RH. On the relation between thrombophlebitis of inferior vena cava and occlusion of the hepatic veins (Endophlebitis hepatica obliterans). Bull Johns Hopkins Hosp 1933;53:162–171

36.

Hutchinson R, Simpson SL. Occlusion of the hepatic veins with cirrhosis of the liver. Arch Dis Child 1930;5:167–182. doi:10.1136/adc.5.27.167 CrossRef

37.

Kibel MA, Marsden HB. Inferior vena cava and hepatic vein thrombosis: the Chiari syndrome in childhood. Arch Dis Child 1956;31:225–228. doi:10.1136/adc.31.157.225 PubMedCrossRef

38.

Kage M, Arakawa M, Kojiro M, Okuda K. Histopathology of membranous obstruction of the inferior vena cava in the Budd-Chiari syndrome. Gastroenterology 1992;102:2081–2090PubMed

39.

Wanless IR, Liu JJ, Butany J. Role of thrombosis in the pathogenesis of congestive hepatic fibrosis (cardiac cirrhosis). Hepatology 1995;21:1232–1237PubMed

40.

Blum HE, Liang TJ, Wanda JR. Hepatitis B Virus Carrier and Hepatocellular Carcinoma. In Bianchi L, Gerok W, Maier K-P, Deinhardt F, editors. Infectious Disease of the Liver. Dordrecht, The Netherlands: Kulwer Academic; 1990. 261–273

41.

Wands JR, Blum HE. Primary hepatocellular carcinoma. N Engl J Med 1991;325:729–731PubMed

42.

Kika G. Statistical study of 110 cases with primary liver carcinoma at the Department of Pathology, Tokyo University School of Medicine. Gann 1927;23:341. in Japanese

43.

Shrestha SM. Hepatic venous outflow obstruction in Nepal. Trop Gastroenterol 1996;17:165–171PubMed

44.

Pleasants JH. Obstruction of the inferior vena cava with a report of eighteen cases. Johns Hopkins Hosp Rep 1911;16:363–548

45.

Luengrojanakul P, Vareesangthip K, Chainuvati T, Murata K, Tsuda F, Tokita H, et al. Hepatitis C virus infection in patients with chronic liver disease or chronic renal failure and blood donors in Thailand. J Med Virol 1994;44:257–292. doi:10.1002/jmv.1890440313 CrossRef

46.

Hadiwandowo S, Tsuda F, Okamoto H, Tokita H, Wang Y, Tanaka T, et al. Hepatitis B virus subtypes and hepatitis C Virus genotypes in Patients with chronic liver disease or on maintenance hemodialysis in Indonesia. J Med Virol 1994;43:182–186. doi:10.1002/jmv.1890430216 PubMedCrossRef

47.

Panigrahi AK, Panda SK, Dixit RK, Rao KVS, Acharya SK, Dasarathy S, et al. Magnitude of hepatitis C virus infection in India: prevalence in healthy blood donors, acute and chronic liver diseases. J Med Virol 1997;51:167–174. doi:10.1002/(SICI)1096-9071(199703)51:3<167::AID-JMV5>3.0.CO;2-4 PubMedCrossRef

48.

Zaman S, Khan M, Alam K, Williams R. Primary hepatocellular carcinoma and viral hepatitis B and C infection in Bangladeshi subjects. J Trop Med Hyg 1995;98:64–68PubMed

49.

Khan M, Ahmad N. Seroepidemiology of HBV and HCV in Bangladesh. Int Hepatol Commun 1996;5:27–29. doi:10.1016/S0928-4346(96)82007-X CrossRef

50.

Wang B, Ma W, Sulaiman A, Noer S, Sumoharjo S, Sumarsidi D, et al. Demographic, clinical, and virological characteristics of hepatocellular carcinoma in Asia: survey of 414 patients from four countries. J Med Virol 2002;67:394–400. doi:10.1002/jmv.10087 PubMedCrossRef

51.

Wang ZG, Zhang FJ, Li XQ, Meng QY. Management of Budd-Chiari syndrome: what is the best approach? J Gastroenterol Hepatol 2004;19:S212–S218. doi:10.1111/j.1440-1746.2004.03677.x CrossRef

52.

Shrestha SM. Membranous obstruction of the hepatic portion of the inferior vena cava: is this an under diagnosed entity in developing countries. Am J Gastroenterol 1995;90(2):303–306PubMed

Title: Liver cirrhosis and hepatocellular carcinoma in hepatic vena cava disease, a liver disease caused by obstruction of inferior vena cava
Author: Santosh Man Shrestha
Publication date: 01-06-2009
Publisher: Springer-Verlag
Published in: Hepatology International / Issue 2/2009
Print ISSN: 1936-0533
Electronic ISSN: 1936-0541
DOI: https://doi.org/10.1007/s12072-009-9122-5

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Purpose

Method

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 2/2009

Liver fibrosis: consensus recommendations of the Asian Pacific Association for the Study of the Liver (APASL)

Association of IL-18 promoter polymorphism with liver disease severity in HCV-infected patients

Hepatitis A outbreaks in China during 2006: application of molecular epidemiology

Systemic and pulmonary hemodynamics in patients with extrahepatic portal vein obstruction is similar to compensated cirrhotic patients

Induction of tropomyosin during hepatic stellate cell activation and the progression of liver fibrosis

High serum adiponectin correlates with advanced liver disease in patients with chronic hepatitis B virus infection

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

At a glance: The STEP trials